NAS:INGN (USA) Also Trade In: Germany

Inogen Inc $ 35.61 0.77 (2.21%)

Avg Vol (1m):
Market Cap $:
785.13 Mil
Enterprise Value $:
587.75 Mil
P/E (TTM):
Warning! GuruFocus has detected 1 Severe warning sign with INGN. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

INGN News and Headlines - Inogen

GuruFocus Articles Total 12
  • 1

So far, this January isn’t running true to form. The market has risen, but small stocks are lagging and last year’s losers are getting hammered again

When I was a boy, my father took me to the race track. I was entranced by the Daily Racing Form, which contained a wealth of information about every horse’s past performance.

“There’s one problem,” my father said. “The horses don’t read the form.”

As I look at the stock market action in January, I’m reminded of my father’s remark. Traditionally, January is famous in the stock market for three things:

  • The market usually rises.
  • Small stocks usually beat big ones.
  • Last year’s losers often bounce back.

So far, this January isn’t running true to form. The market

114 Views    John Dorfman    2020-01-27 15:37
Inogen, Madrigal Pharmaceuticals have overweight recommendation ratings

The following securities are falling knives, meaning their share prices have declined more than 59% over the last 52 weeks. Some investors are interested in these stocks because they believe the companies will rebound and reward them with impressive returns.

Investors are also aware that such a large decline can be a sign of financial distress, which will cause a major loss if it turns to insolvency.

The risk is very high with this kind of investment, but if investors look for companies that have no debt and a moderate to high current ratio, the risk can be significantly decreased.

205 Views    Alberto Abaterusso    2019-06-07 16:29
Guru drastically boosts position in medical device company

Billionaire investor Steven Cohen (Trades, Portfolio), who leads Point72 Asset Management, disclosed on May 10 that he expanded his stake in Intersect ENT Inc. (XENT) by 221.55%.

The guru’s Connecticut-based hedge fund seeks to generate superior risk-adjusted returns using long, short, macro and systematic strategies.

According to GuruFocus Real-Time Picks, a Premium feature, Cohen invested in 1.16 million shares of the California-based medical devices manufacturer on May 9. He now holds 1.68 million shares of the company, which represent approximately 0.23% of the equity portfolio. During the quarter, the stock traded for an average price of

369 Views    Sydnee Gatewood    2019-05-14 16:18
Guru adds biotech company to health care holdings

Expanding his position in the health care space, billionaire investor Steven Cohen (Trades, Portfolio), who leads Point72 Asset Management, disclosed a 7.3% stake in Aptevo Therapeutics Inc. (APVO) on March 11.

In order to generate superior risk-adjusted returns, the guru’s Connecticut-based hedge fund uses long, short, macro and systematic strategies.

According to a Schedule 13G filing with the Securities and Exchange Commission, Cohen invested in 3.2 million shares of the Seattle-based biotechnology company.

The company, which develops novel oncology, autoimmune and hematology therapeutics, has a $20.14 million market cap; its shares were trading around 88 cents

349 Views    Sydnee Gatewood    2019-03-14 16:13
Billionaire guru discloses stake in respiratory medical device manufacturer

Point72 Asset Management leader Steven Cohen (Trades, Portfolio) revealed a 5.28% stake in Inogen Inc. (INGN) on Nov. 28.

To generate superior risk-adjusted returns, the billionaire investor’s Connecticut-based hedge fund utilizes long, short, macro and systematic strategies.

According to GuruFocus real-time picks, a premium feature, Cohen picked up 1.14 million shares of the Goleta, California-based company for an average price of $141.24 per share, allocating 0.66% of the equity portfolio to the position. He previously sold out of the stock in the third quarter of 2017.

The medical device manufacturer, which makes portable oxygen concentrators for

184 Views    Sydnee Gatewood    2018-11-30 17:29
Intel has outperformed the S&P 500 by 9.5%

According to the GuruFocus All-in-One Guru Screener, the following stocks have outperformed the Standard & Poor's 500 index over the past 12 months and were bought by gurus during the last quarter.

Inogen Inc. (INGN) has a market cap of $5.47 billion. It has outperformed the S&P 500 Index by 129.8% over the past 12 months.


The stock is trading with a price-book ratio of 20.42. According to the discounted cash flow calculator, the stock is overpriced by 1,581% at $255.98 per share. As of Friday, the stock price is 179.76% above its

109 Views    Tiziano Frateschi    2018-09-23 14:45
Gogo, Inogen rise on quarterly financial data

Shares of Gogo Inc. (GOGO) jumped more than 3% after reporting a second-quarter loss per share of 47 cents on $224.46 million in revenue, a 31.6% year-over-year increase. The company beat earnings estimates by 28 cents and revenue expectations by $19.82 million.

Consolidated revenue increased to $227.5 million. Service revenue increased 3% to $159.1 million. Equipment revenue increased to $68.4 million, up from $18.7 million in the prior-year quarter.

Adjusted earnings before interest, taxes, depreciation and amortization increased 90% to $18.9 million.

19 Views    Omar Venerio    2018-08-08 18:32
The company beats earnings, revenue estimates and raises guidance

In Tuesday trading, shares of Inogen Inc. (INGN) jumped more than 23% after reporting first-quarter earnings per share of 48 cents on revenue of $79.05 million, up 50.6% year over year. The company managed to beat earnings estimates by 19 cents and revenue expectations by $15.19 million.

Further, adjusted earnings before interest, taxes, depreciation and amortization grew 42.7% from the prior-year quarter to $15.5 million.

“In what is historically a seasonally slower quarter, we were able to generate record revenues driven by strong sales in both our domestic direct-to-consumer and domestic business-to-business channels,” CEO Scott Wilkinson said.

19 Views    Omar Venerio    2018-05-01 22:21
Guru sells LendingClub, Antero Resources and Inogen, buys Atara Biotherapeutics and Tesaro

David Swensen (Trades, Portfolio) has been the chief investment officer of Yale University's endowment fund since 1985. He is responsible for managing and investing the university's endowment assets and investment funds. Here are his most weighted stocks that got new positions or lost their positions in the portfolio during the third quarter.

During the second quarter Swensen bought 319,273 shares of Alexion Pharmaceuticals Inc. (ALXN) for an average price of $172.57; in the third quarter he sold his shares for more than its purchase price at $182.41 and gained 6%. The deal

1156 Views    Samira Meskini    2015-12-03 18:27

In 30 years as chief investment officer at Yale University, David Swensen (Trades, Portfolio) has been quite successful. In the last decade, he has enjoyed an annual return of more than 17.2% on his investments. In his personal investments, Swensen applies knowledge he has gained in that role as well as in his six years on Wall Street prior to taking the job at Yale

Swensen’s most significant second-quarter transaction was his purchase of a 3,258,000-share stake in Vanguard MSCI Emerging Markets ETF (VWO). Swensen paid an average price of $42.57 per share in a deal that

1833 Views    David Goodloe    2015-08-19 21:27

At the end of the second quarter of 2015, the hedge fund Redmond Asset Management LLC reported a total value of its portfolio of $202,512,000 with a increase of 2.10% since the previous quarter.

During Q2 2015, the hedge fund bought eight new stocks and increased 75 of its stakes. The following are the most heavily weighted buys during the quarter.

It bought shares of Harley-Davidson Inc (HOG) with an impact of 0.97% on its portfolio. The company produces and sells heavyweight motorcycles, as well as offers motorcycle parts,

1334 Views    Tiziano Frateschi    2015-08-14 20:24

The third quarter of 2014 was the least active trading quarter for guru David Swensen (Trades, Portfolio) in five years. Swensen, the chief investment officer at Yale University, traded in only five stocks in the third quarter.

Perhaps Swensen has been devoting most of his attention to his job. A Wall Street veteran when he took the post at Yale in 1985, Swensen is credited with raising the value of the school’s endowment assets and investment funds to nearly $24 billion, which is worth more than 15 times its value when Swensen took the job.


1664 Views    David Goodloe    2015-01-06 22:22

Headlines Total 61
  • 1

2020-06-04 $ 38.11 (-0.7%)
2020-05-28 $ 38.38 (2.35%)
2020-05-08 $ 40.15 (-2.57%)
2020-05-06 $ 39.51 (-25.31%)
2020-05-05 $ 52.9 (5.25%)
2020-04-29 $ 52 (-1.89%)
2020-04-28 $ 53 (2.89%)
2020-03-26 $ 54.89 (4.55%)
2020-03-25 $ 52.5 (2.86%)
2019-06-28 $ 65.49 (1.82%)
2019-05-06 $ 95.15 (3.78%)
2019-05-04 $ 91.68 (4.05%)
2019-05-03 $ 91.68 (4.05%)
2019-05-02 $ 88.11 (2.63%)
2019-05-01 $ 85.85 (-1.66%)
2019-04-30 $ 87.3 (0.34%)
2019-04-27 $ 86.22 (3.94%)
2019-04-26 $ 86.22 (3.94%)
2019-04-25 $ 82.95 (-0.54%)
2019-04-24 $ 83.4 (-0.76%)
2019-04-20 $ 78.69 (%)
2019-04-19 $ 78.69 (%)
2019-04-17 $ 79.91 (-2.87%)
2019-04-12 $ 84.83 (-3.61%)
2019-04-06 $ 93.37 (1.03%)
2019-04-04 $ 92.42 (2.46%)
2019-04-03 $ 90.18 (-1.17%)
2019-03-29 $ 93.75 (1.31%)
2019-03-28 $ 93.75 (1.31%)
2019-03-26 $ 91.78 (1.84%)
2019-03-23 $ 90.12 (-4.82%)
2019-03-21 $ 94.68 (1.51%)
2019-03-20 $ 96.11 (0.42%)
2019-03-14 $ 97.44 (1.67%)
2019-03-13 $ 95.84 (-0.46%)
2019-03-12 $ 96.28 (2.48%)
2019-03-11 $ 96.28 (2.48%)
2019-03-09 $ 93.95 (-3.37%)
2019-03-08 $ 93.95 (-3.37%)
2019-03-07 $ 97.23 (-1.3%)
2018-11-30 $ 147.36 (2.28%)
Total 61
  • 1